Dr. Matthew (Matt) Gevaert is Chief Executive Officer directing KIYATEC's business and commercial development as well as fostering strategic scientific, financial, and corporate partnerships.  Possessing a background which combines both business and technology, Matt previously led the commercialization of Clemson University’s biomedical and biotechnology intellectual property portfolio since 2004, working with both entrepreneurial start-ups and large, industry leading corporations.  Together with the company’s scientific and development partners, he is focused on advancing the platform technology and related products toward commercial utilization.

Matt grew up in Ontario, Canada and graduated from the University of Waterloo with a bachelor’s degree in Applied Chemistry.  He also holds a masters and doctorate degree in Bioengineering from Clemson University, one of the world’s oldest biomedical engineering programs, which since 1963 has been a leader in biomaterials research.  Matt has held a variety of professional roles with 3M, Dow Chemical, and Merck, and has additional experience as sole proprietor of Edge Biomedical, a biomaterials consulting practice.  He maintains current appointments as adjunct professor in the Clemson University Department of Bioengineering and as visiting professor in the Spiro Institute for Entrepreneurial Leadership, where he teaches a graduate course in biomedical entrepreneurship for scientists and engineers.